NL-OMON35785已完成不适用
Axial Spondyloarthritis in Primary care patients with chronic low back pain; a cross-sectional stratified validation study - CAFASPA-II
The Rotterdam Institute of Rheumatology0 个研究点目标入组 800 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •A-Specific low back pain
- •Symptom duration more than 12 weeks
- •Age between 20-45
排除标准
- •Impossible to communicate
- •Low back pain due to trauma
- •Metal protheses
- •Claustrofobia
- •Unwilling to participate in MRI
研究者
相似试验
进行中（未招募）
1 期
Treating patients with early axial spondyloarthritis to target – a 1 year randomized controlled study taking an intense treatment approach versus routine treatment (STRIKE)EUCTR2015-005398-18-DEAbbVie Deutschland GmbH & Co. KG22
尚未招募
3 期
Patients with axial spondyloarthritis and high disease activity treating with systemic glucocorticoids: a double-blinded randomised controlled trialNL-OMON52017Franciscus Gasthuis & Vlietland38
尚未招募
不适用
A prospective cohort study of Spondyloarthritis in Japan.spondyloarthritisJPRN-UMIN000021245The Japan Spondyloarthritis Society Hyogo College of Medicine500
进行中（未招募）
不适用
se of placebo in treatment of Axial SpondyloarthritisAxial SpondyloarthritisEUCTR2013-000098-65-NOniversity of Tromsø
已完成
3 期
Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of ASAxial SpondyloarthritisNonradiographic Axial SpondyloarthritisNr-axSpANCT02552212UCB BIOSCIENCES GmbH317